ACS Stock Overview
Offers healthcare services in Greece and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Athens Medical C.S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.49 |
| 52 Week High | €1.85 |
| 52 Week Low | €1.26 |
| Beta | 0 |
| 1 Month Change | 7.19% |
| 3 Month Change | 10.78% |
| 1 Year Change | -10.51% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 19.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.3% | 3.9% | 3.0% |
| 1Y | -10.5% | 31.0% | 12.8% |
Return vs Industry: ACS underperformed the German Healthcare industry which returned 31% over the past year.
Return vs Market: ACS underperformed the German Market which returned 12.8% over the past year.
Price Volatility
| ACS volatility | |
|---|---|
| ACS Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ACS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ACS's weekly volatility has decreased from 8% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 3,230 | Vasilios Apostolopoulos | www.iatriko.gr |
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions.
Athens Medical C.S.A. Fundamentals Summary
| ACS fundamental statistics | |
|---|---|
| Market cap | €146.15m |
| Earnings (TTM) | €9.07m |
| Revenue (TTM) | €249.37m |
0.0x
P/E Ratio0.0x
P/S RatioIs ACS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACS income statement (TTM) | |
|---|---|
| Revenue | €249.37m |
| Cost of Revenue | €185.18m |
| Gross Profit | €64.19m |
| Other Expenses | €55.12m |
| Earnings | €9.07m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ACS perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 00:12 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Athens Medical C.S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Antonis Diapoulis | Alpha Finance Investment Services S.A. |